Publicaciones en colaboración con investigadores/as de University of Manchester (15)

2019

  1. Rational Design, Structure–Activity Relationship, and Immunogenicity of Hypoallergenic Pru p 3 Variants

    Molecular Nutrition and Food Research, Vol. 63, Núm. 18

2017

  1. Reparative effects of interleukin-1 receptor antagonist in young and aged/co-morbid rodents after cerebral ischemia

    Brain, Behavior, and Immunity, Vol. 61, pp. 117-126

2016

  1. A cross-laboratory preclinical study on the effectiveness of interleukin-1 receptor antagonist in stroke

    Journal of Cerebral Blood Flow and Metabolism, Vol. 36, Núm. 3, pp. 596-605

  2. Efficacy of Alteplase in a Mouse Model of Acute Ischemic Stroke: A Retrospective Pooled Analysis

    Stroke, Vol. 47, Núm. 5, pp. 1312-1318

2015

  1. 18F-GE-180: a novel TSPO radiotracer compared to 11C-R-PK11195 in a preclinical model of stroke

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 42, Núm. 3, pp. 503-511

  2. Development of a hypoallergenic recombinant parvalbumin for first-in-man subcutaneous immunotherapy of fish allergy

    International Archives of Allergy and Immunology, Vol. 166, Núm. 1, pp. 41-51

  3. Small Molecule Inhibition of ERK Dimerization Prevents Tumorigenesis by RAS-ERK Pathway Oncogenes

    Cancer Cell, Vol. 28, Núm. 2, pp. 170-182

2014

  1. Streptococcus pneumoniae worsens cerebral ischemia via interleukin 1 and platelet glycoprotein Ibα

    Annals of Neurology, Vol. 75, Núm. 5, pp. 670-683

  2. Surgical manipulation compromises leukocyte mobilization responses and inflammation after experimental cerebral ischemia in mice

    Frontiers in Neuroscience

2013

  1. Citicoline (CDP-choline) increases Sirtuin1 expression concomitant to neuroprotection in experimental stroke

    Journal of Neurochemistry, Vol. 126, Núm. 6, pp. 819-826

  2. Silent information regulator 1 protects the brain against cerebral ischemic damage

    Stroke, Vol. 44, Núm. 8, pp. 2333-2337

  3. The immune system in stroke: Clinical challenges and their translation to experimental research

    Journal of Neuroimmune Pharmacology, Vol. 8, Núm. 4, pp. 867-887

2012

  1. Daidzein has neuroprotective effects through ligand-binding-independent PPARγ activation

    Neurochemistry International, Vol. 61, Núm. 1, pp. 119-127

  2. Delayed administration of interleukin-1 receptor antagonist reduces ischemic brain damage and inflammation in comorbid rats

    Journal of Cerebral Blood Flow and Metabolism, Vol. 32, Núm. 9, pp. 1810-1819

  3. Fast: Towards safe and effective subcutaneous immunotherapy of persistent life-threatening food allergies

    Clinical and Translational Allergy, Vol. 2, Núm. 1